AbbVie Inc. (4AB.DE)
Develops and sells medicines for cancer, autoimmune diseases, and cosmetic treatments like Botox.
234.40+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+39.2%
The outlook
AbbVie is trading near the top of its 52-week range and well above its longer-term moving averages, reflecting sustained upward momentum. The stock carries a notably high trailing P/E of 130.9, and analyst coverage appears thin on this German exchange listing. Current price positioning suggests the stock is at an extended valuation relative to recent earnings.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$414.14B
52-wk high
234.40
52-wk low
162.80
50-day avg
205.88
200-day avg
192.80
Trailing P/E
130.9